Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies
出版年份 2017 全文链接
标题
Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies
作者
关键词
Coronary microvascular dysfunction, Non-ischemic cardiomyopathy, Coronary flow reserve, Cardiac PET
出版物
HEART FAILURE REVIEWS
Volume 22, Issue 4, Pages 455-464
出版商
Springer Nature
发表日期
2017-06-03
DOI
10.1007/s10741-017-9628-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Human Microcirculation
- (2016) David D. Gutterman et al. CIRCULATION RESEARCH
- Challenges in the Diagnosis of Anderson-Fabry Disease
- (2016) Ali J. Marian JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- AL (Light-Chain) Cardiac Amyloidosis
- (2016) Rodney H. Falk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes
- (2015) Maulik D. Majmudar et al. European Heart Journal-Cardiovascular Imaging
- Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis
- (2014) Sharmila Dorbala et al. JACC-Heart Failure
- Relationship of Delayed Enhancement by Magnetic Resonance to Myocardial Perfusion by Positron Emission Tomography in Hypertrophic Cardiomyopathy
- (2013) Paco E. Bravo et al. Circulation-Cardiovascular Imaging
- Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease
- (2013) Benedetta Tomberli et al. EUROPEAN JOURNAL OF HEART FAILURE
- Coronary microvascular dysfunction in primary cardiomyopathies
- (2013) R Spoladore et al. HEART
- PET/CT Assessment of Symptomatic Individuals with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy
- (2012) P. E. Bravo et al. JOURNAL OF NUCLEAR MEDICINE
- Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins
- (2011) Raymond Q. Migrino et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction
- (2011) Stefan A.J. Timmer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations
- (2011) Iacopo Olivotto et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocardial Structural, Perfusion, and Metabolic Correlates of Left Bundle Branch Block Mechanical Derangement in Patients With Dilated Cardiomyopathy
- (2010) Pier Giorgio Masci et al. Circulation-Cardiovascular Imaging
- The heart in Fabry's disease
- (2009) Mary N. Sheppard CARDIOVASCULAR PATHOLOGY
- Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation
- (2009) F. T. Range et al. JOURNAL OF NUCLEAR MEDICINE
- Twenty-four-month α-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters
- (2008) J. W. Koskenvuo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Intravascular ultrasound assessment of coronary artery involvement in Fabry disease
- (2008) T. Kovarnik et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy
- (2008) B. Sotgia et al. JOURNAL OF NUCLEAR MEDICINE
- Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy
- (2007) Paul Knaapen et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started